|
TRIP4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.79140000003508E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
3.234200E-01 |
| Stage1-vs-Stage3 |
2.918000E-02 |
| Stage1-vs-Stage4 |
2.210299999994E-05 |
| Stage2-vs-Stage3 |
3.242500E-02 |
| Stage2-vs-Stage4 |
1.002500E-03 |
| Stage3-vs-Stage4 |
5.606000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.06740000000083E-06 |
| Normal-vs-Asian |
5.32907051820075E-15 |
| Caucasian-vs-AfricanAmerican |
1.682440E-02 |
| Caucasian-vs-Asian |
7.708400E-01 |
| AfricanAmerican-vs-Asian |
4.112300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.10622663543836E-15 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
5.585600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62492241884138E-12 |
| Normal-vs-Age(81-100Yrs) |
2.602400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.419200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.372600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.511400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.684400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.296200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.537400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.814020E-04 |
| Classical-VS-Follicular |
7.249900E-04 |
| Classical-VS-Other |
9.608600E-01 |
| Classical-VS-Normal |
1.62470037423645E-12 |
| Tall-VS-Follicular |
6.77300000528902E-08 |
| Tall-VS-Other |
3.332200E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
2.782400E-01 |
| Follicular-VS-Normal |
3.68010000029173E-07 |
| Other-VS-Normal |
1.377290E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
5.94830000000268E-05 |
|
|
